Beyond weight reduction, baseline T2DM duration, preoperative use of intensive insulin regimens, and poorer glycemic control, have been consistently associated with lower rates of T2DM remission and higher risk of relapse [27, 28]. This evidence concerns the gene INS and type 2 diabetes mellitus.